Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Nathalie Garçon & Marcelle Van Mechelen. (2011) Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems. Expert Review of Vaccines 10:4, pages 471-486.
Read now
Read now
G William Letson, Pratap Singhasivanon, Eduardo Fernandez, Nihal Abeysinghe, Juan Jose Amador, Harold S Margolis & Robert Edelman. (2010) Dengue vaccine trial guidelines and role of large-scale, post proof-of-concept demonstration projects in bringing a dengue vaccine to use in dengue endemic areas. Human Vaccines 6:10, pages 802-809.
Read now
Read now
Diane M Harper. (2009) Currently approved prophylactic HPV vaccines. Expert Review of Vaccines 8:12, pages 1663-1679.
Read now
Read now
Dexiang Chen & Debra Kristensen. (2009) Opportunities and challenges of developing thermostable vaccines. Expert Review of Vaccines 8:5, pages 547-557.
Read now
Read now
Articles from other publishers (7)
Dongyou LiuJanice Rusnak & Leonard Smith. 2014. Manual of Security Sensitive Microbes and Toxins. Manual of Security Sensitive Microbes and Toxins
451
466
.
Hesham Rashwan, Ismarulyusda Ishak & Nurhidayah Sawalludin. (2013) Knowledge and Views of Secondary School Students in Kuala Lumpur on Cervical Cancer and its Prevention. Asian Pacific Journal of Cancer Prevention 14:4, pages 2545-2549.
Crossref
Crossref
Hesham H. Rashwan, Nur Zakiah N. Mohd Saat & Dahlia Nadira Abd Manan. (2012) Knowledge, Attitude and Practice of Malaysian Medical and Pharmacy Students Towards Human Papillomavirus Vaccination. Asian Pacific Journal of Cancer Prevention 13:5, pages 2279-2283.
Crossref
Crossref
Jerome H Kim, Supachai Rerks-Ngarm, Jean-Louis Excler & Nelson L Michael. (2010) HIV vaccines: lessons learned and the way forward. Current Opinion in HIV and AIDS 5:5, pages 428-434.
Crossref
Crossref
Tino F. Schwarz. (2009) Clinical update of the AS04-Adjuvanted human Papillomavirus-16/18 cervical cancer vaccine, cervarix®. Advances in Therapy 26:11, pages 983-998.
Crossref
Crossref
Jian-Kui Liu, Xi-Lin Hou, Chun-Hua Wei, Li-Yun Yu, Xiao-Jie He, Gui-Hua Wang, Jong-Soo Lee & Chul-Joong Kim. (2009)
Induction of Immune Responses in Mice after Oral Immunization with Recombinant
Lactobacillus casei
Strains Expressing Enterotoxigenic
Escherichia coli
F41 Fimbrial Protein
. Applied and Environmental Microbiology 75:13, pages 4491-4497.
Crossref
Crossref
R. Tarricone, C. Giaquinto, N. Largeron & M. Trichard. (2013) Analisi economica dei costi e dei benefici dell’implementazione di un programma di prevenzione antirotavirus con il vaccino pentavalente in ItaliaHealth benefits and economic impact of implementing a pentavalent rotavirus vaccination program in Italy. PharmacoEconomics Italian Research Articles 11:1, pages 1-13.
Crossref
Crossref